A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 4, 2010, Pages 793-797

  Nakagami, Yasuhiro ^a   Kawashima, Kayo ^a   Etori, Maki ^a   Yonekubo, Kazuki ^a   Suzuki, Chie ^a   Jojima, Takaaki ^a   Kuribayashi, Takeshi ^a   Nara, Futoshi ^a   Yamashita, Makoto ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; LIPOPOLYSACCHARIDE; OVALBUMIN; RS 1269; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CHO CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EAR SWELLING; FEMALE; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SWELLING; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; BENZAMIDES; CHEMOTAXIS, LEUKOCYTE; EAR, EXTERNAL; EDEMA; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MORPHOLINES; OVALBUMIN; RECEPTORS, CCR4; SHOCK, SEPTIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77956824364     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00578.x     Document Type: Article

References (33)

1. Luster AD. Antichemokine immunotherapy for allergic diseases. Curr Opin Allergy Clin Immunol 2001 1 : 561 7.
2. Schwarz MK, Wells TN. New therapeutics that modulate chemokine networks. Nat Rev Drug Discov 2002 1 : 347 58.
3. Hwang ST. Mechanisms of T-cell homing to skin. Adv Dermatol 2001 17 : 211 41.
4. Pease JE, Horuk R. Chemokine receptor antagonists: Part 1. Expert Opin Ther Pat 2009 19 : 39 58.
5. Bonecchi R, Bianchi G, Bordignon PP, D'ambrosio D, Land R, Borsatti A et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 34.
6. Imai T, Nagira M, Takaga S, Kakizaki M, Nishimura M, Wang J et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999 11 : 81 8.
7. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002 2 : 106 15.
8. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000 105 : 860 76.
9. Pastar Z, Lipozencic J, Ljubojevid S. Etiopathogenesis of atopic dermatitis - an overview. Acta Dermatovenerol Croat 2005 13 : 54 62.
10. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000 115 : 640 6.
11. Galli G, Chantry D, Annunziato F, Romagnani P, Cosmi L, Lazzeri E et al. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 2000 30 : 204 10.
12. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokineCCL17 and macrophage-derived chemokineCCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 2002 14 : 767 73.
13. + T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001 117 : 188 96.
14. Vestergaard C, Deleuran M, Gesser B, Larsen CG. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2003 149 : 457 63.
15. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999 400 : 776 80.
16. Vestergaard C, Deleuran M, Gesser B, Larsen CG. Thymus- and activation-regulated chemokine (TARCCCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice. Exp Dermatol 2004 13 : 265 71.
17. Fujimoto S, Uratsuji H, Saeki H, Kagami S, Tsunemi Y, Komine M et al. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction. Cytokine 2008 44 : 172 8.
18. Tsunemi Y, Saeki H, Nakamura K, Nagakubo D, Nakayama T, Yoshie O et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 2006 36 : 2116 27.
19. Nakagami Y, Kawashima K, Yonekubo K, Etori M, Jojima T, Miyazaki S et al. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice. Eur J Pharmacol 2009 624 : 38 44.
20. Togawa M, Kiniwa M, Nagai H. The roles of IL-4, IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice. Life Sci 2001 69 : 699 705.
21. Gonda A, Gal I, Szanto S, Sarraj B, Glant TT, Hunyadi J et al. CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol 2005 14 : 700 8.
22. Chvatchko Y, Hoogewerf AJ, Meyer A, Alouani S, Juillard P, Buser R et al. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med 2000 191 : 1755 64.
23. Gaga M, Frew AJ, Varney VA, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J Immunol 1991 147 : 816 22.
24. Tomimori Y, Tsuruoka N, Fukami H, Saito K, Horikawa C, Saito M et al. Role of mast cell chymase in allergen-induced biphasic skin reaction. Biochem Pharmacol 2002 64 : 1187 93.
25. - mice. FASEB J 2002 16 : 1313 5.
26. + regulatory T cells. J Exp Med 2001 194 : 847 53.
27. + regulatory T cells bear functional skin-homing receptors. J Immunol 2006 177 : 4484 94.
28. Inngjerdingen M, Damaj B, Maghazachi AA. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 2000 164 : 4048 54.
29. Ness TL, Ewing JL, Hogaboam CM, Kunkel SL. CCR4 is a key modulator of innate immune responses. J Immunol 2006 177 : 7531 9.
30. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999 189 : 611 4.
31. Brown KL, Cosseau C, Gardy JL, Hancock RE. Complexities of targeting innate immunity to treat infection. Trends Immunol 2007 28 : 260 6.
32. Ishii M, Hogaboam CM, Joshi A, Ito T, Fong DJ, Kunkel SL. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur J Immunol 2008 38 : 2290 302.
33. + T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation. Pharmacology 2009 84 : 171 82.